Indaptus Therapeutics Stock Buy Hold or Sell Recommendation

INDP Stock  USD 2.25  0.03  1.35%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Indaptus Therapeutics is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Indaptus Therapeutics given historical horizon and risk tolerance towards Indaptus Therapeutics. When Macroaxis issues a 'buy' or 'sell' recommendation for Indaptus Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Indaptus Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
To learn how to invest in Indaptus Stock, please use our How to Invest in Indaptus Therapeutics guide.
Note, we conduct extensive research on individual companies such as Indaptus and provide practical buy, sell, or hold advice based on investors' constraints. Indaptus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

Execute Indaptus Therapeutics Buy or Sell Advice

The Indaptus recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Indaptus Therapeutics. Macroaxis does not own or have any residual interests in Indaptus Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Indaptus Therapeutics' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Indaptus TherapeuticsBuy Indaptus Therapeutics
Strong Sell

Market Performance

Very WeakDetails



Hype Condition

Over hypedDetails

Current Valuation


Odds Of Distress


Economic Sensitivity

Moves indifferently to market movesDetails

Investor Sentiment


Analyst Consensus


Financial Strenth (F Score)


Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Indaptus Therapeutics has a Mean Deviation of 3.99, Standard Deviation of 5.24 and Variance of 27.48
We provide advice to complement the regular expert consensus on Indaptus Therapeutics. Our dynamic recommendation engine utilizes a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Indaptus Therapeutics is not overpriced, please check out all Indaptus Therapeutics fundamentals, including its total debt, and the relationship between the price to book and short ratio . Please also validate Indaptus Therapeutics number of shares shorted to confirm your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself in the current economic cycle.

Indaptus Therapeutics Trading Alerts and Improvement Suggestions

Indaptus Therapeutics generated a negative expected return over the last 90 days
Indaptus Therapeutics has high historical volatility and very poor performance
Net Loss for the year was (15.42 M) with profit before overhead, payroll, taxes, and interest of 0.
Indaptus Therapeutics currently holds about 33.01 M in cash with (13.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.0, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Indaptus Therapeutics has a frail financial position based on the latest SEC disclosures
Roughly 31.0% of the company shares are held by company insiders
Latest headline from Fibromyalgia Market Report 2034 Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight

Indaptus Therapeutics Returns Distribution Density

The distribution of Indaptus Therapeutics' historical returns is an attempt to chart the uncertainty of Indaptus Therapeutics' future price movements. The chart of the probability distribution of Indaptus Therapeutics daily returns describes the distribution of returns around its average expected value. We use Indaptus Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Indaptus Therapeutics returns is essential to provide solid investment advice for Indaptus Therapeutics.
Mean Return
Value At Risk
Potential Upside
Standard Deviation
   Return Density   
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Indaptus Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Indaptus Stock Institutional Investors

The Indaptus Therapeutics' institutional investors refer to entities that pool money to purchase Indaptus Therapeutics' securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
Morgan Stanley - Brokerage Accounts2024-03-31
Bangor Savings Bank2024-03-31
Wells Fargo & Co2024-03-31
Royal Bank Of Canada2023-12-31
Jpmorgan Chase & Co2024-03-31
Group One Trading, Lp2024-03-31
Qube Research & Technologies2024-03-31
Bank Of America Corp2024-03-31
Vanguard Group Inc2024-03-31
256.3 K
Investment House Llc2024-03-31
102.4 K
Geode Capital Management, Llc2024-03-31
54.8 K
Note, although Indaptus Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Indaptus Therapeutics Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Indaptus Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Indaptus Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Indaptus stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Alpha over Dow Jones
Beta against Dow Jones-0.1
Overall volatility
Information ratio -0.0089

Indaptus Therapeutics Volatility Alert

Indaptus Therapeutics exhibits very low volatility with skewness of 0.65 and kurtosis of 1.21. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Indaptus Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Indaptus Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Indaptus Therapeutics Fundamentals Vs Peers

Comparing Indaptus Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Indaptus Therapeutics' direct or indirect competition across all of the common fundamentals between Indaptus Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Indaptus Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Indaptus Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Indaptus Therapeutics by comparing valuation metrics with those of similar companies.
 Better Than Average     
 Worse Than Average Compare Indaptus Therapeutics to competition
FundamentalsIndaptus TherapeuticsPeer Average
Return On Equity-0.98-0.31
Return On Asset-0.58-0.14
Current Valuation9.62 M16.62 B
Shares Outstanding8.54 M571.82 M
Shares Owned By Insiders30.85 %10.09 %
Shares Owned By Institutions6.88 %39.21 %
Number Of Shares Shorted5.7 K4.71 M
Price To Book2.25 X9.51 X
EBITDA(16.38 M)3.9 B
Net Income(15.42 M)570.98 M
Cash And Equivalents33.01 M2.7 B
Cash Per Share4.00 X5.01 X
Total Debt175.05 K5.32 B
Debt To Equity0 %48.70 %
Current Ratio9.18 X2.16 X
Book Value Per Share1.10 X1.93 K
Cash Flow From Operations(13.41 M)971.22 M
Short Ratio0.15 X4.00 X
Earnings Per Share(1.77) X3.12 X
Target Price10.0
Number Of Employees718.84 K
Market Capitalization19.21 M19.03 B
Total Asset14.92 M29.47 B
Retained Earnings(45.42 M)9.33 B
Working Capital11.22 M1.48 B
Net Asset14.92 M
Note: Acquisition by Karah Hila of 12500 shares of Indaptus Therapeutics at 2.63 subject to Rule 16b-3 [view details]

Indaptus Therapeutics Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Indaptus . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Indaptus Therapeutics Buy or Sell Advice

When is the right time to buy or sell Indaptus Therapeutics? Buying financial instruments such as Indaptus Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2021 2022 2023 2024 (projected)
Interest Expense17.7K588.1K676.3K710.1K
Depreciation And Amortization1.4K1.8K1.3K1.2K

Use Investing Ideas to Build Portfolios

In addition to having Indaptus Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run ISP Thematic Idea Now

ISP Theme
Internet Service Providers (ISP) companies and IT providers specializing in internet technologies. The ISP theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize ISP Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Indaptus Stock Analysis

When running Indaptus Therapeutics' price analysis, check to measure Indaptus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Indaptus Therapeutics is operating at the current time. Most of Indaptus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Indaptus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Indaptus Therapeutics' price. Additionally, you may evaluate how the addition of Indaptus Therapeutics to your portfolios can decrease your overall portfolio volatility.